BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.90
+0.03 (0.38%)
Jan 31, 2025, 4:00 PM EST - Market closed
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 536 employees as of December 31, 2023. The number of employees increased by 5 or 0.94% compared to the previous year.
Employees
536
Change (1Y)
5
Growth (1Y)
0.94%
Revenue / Employee
$769,737
Profits / Employee
-$231,002
Market Cap
1.64B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
BCRX News
- 22 days ago - BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y) - GlobeNewsWire
- 25 days ago - BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 26 days ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy - Seeking Alpha
- 2 months ago - BioCryst Launches ORLADEYO® (berotralstat) in Ireland - GlobeNewsWire
- 3 months ago - BioCryst to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioCryst to Report Third Quarter 2024 Financial Results on November 4 - GlobeNewsWire